Hidradenitis Suppurativa is a chronic, recurring inflammatory skin condition marked by painful boil-like abscesses and nodules in areas where skin rubs together (such as the underarms, groin, or under the breasts). These lesions can form tunnels under the skin and may heal with scarring, making daily activities uncomfortable. HS is not caused by poor hygiene – it’s an immune-related disease, and roughly 1% of people are affected.

HS is more than just a skin problem. In fact, it’s associated with many other health issues (studies note HS has an even higher overall comorbidity burden than psoriasis). People with HS often have other conditions alongside it – for example, metabolic and cardiovascular disorders like diabetes, high blood pressure, or heart disease are common in HS. It can also take a toll on mental health; patients with HS experience higher rates of depression and anxiety due to the chronic pain and social stress of the disease. All these related conditions need attention too, because HS is not “just skin deep.”

The good news is that treatment and research for HS are advancing. There are effective therapies available now (such as antibiotics, retinoids, or biologic medications), and even better treatments are on the horizon. By participating in a clinical trial, HS patients can access promising new therapies – sometimes years before they become available to everyone else^[1]. These might include new immune-targeted medications (potentially in pill form instead of injections) or options with fewer side effects. In other words, research gives patients a chance to try tomorrow’s medicines today, under careful medical supervision.

Sources:
[1] Cancer Clinical Trials | UNM Cancer Center